The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologistsnews2026-09-04T23:42:44+00:00September 4th, 2026|The New York Times|
The Search for New Cures Is Brokennews2026-09-04T11:27:49+00:00September 4th, 2026|The New York Times|
A Guide to Covid, Flu and R.S.V. Vaccines This Fallnews2026-09-02T17:07:44+00:00September 2nd, 2026|The New York Times|
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Futurenews2026-09-01T17:09:01+00:00September 1st, 2026|The New York Times|
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugsnews2026-08-31T16:43:57+00:00August 31st, 2026|The New York Times|
Walmart to Pay $50 Million to Settle Opioid Lawsuit, US Saysnews2026-08-29T01:08:49+00:00August 29th, 2026|The New York Times|
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Manynews2026-08-27T09:02:45+00:00August 27th, 2026|The New York Times|
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancernews2026-08-26T16:54:01+00:00August 26th, 2026|The New York Times|
Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?news2026-08-20T15:07:16+00:00August 20th, 2026|The New York Times|
Moderna’s Shift to Cancer Company Lifts Stock Up 177%news2026-08-20T14:23:51+00:00August 20th, 2026|The New York Times|
